TNFA
TNF Pharmaceuticals, Inc. Common Stock
TNFA
TNFA
33 hedge funds and large institutions have $65.5K invested in TNF Pharmaceuticals, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.
Holders
33
Holders Change
+9
Holders Change %
+37.5%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
4
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$23.6K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$7.99K |
| 3 |
TSS
3
Two Sigma Securities
New York
|
$6.21K |
| 4 |
4
Goldman Sachs
New York
|
$5.58K |
| 5 |
5
Jane Street
New York
|
$4.33K |
Top Sellers
| 1 |
1
Geode Capital Management
Boston,
Massachusetts
|
$2.9K |
| 2 |
AI
2
Arvest Investments
Rogers,
Arkansas
|
$0 |
| 3 |
3
Group One Trading
Chicago,
Illinois
|
$40 |
